News
18 Mar 2026
AstraZeneca Pharma India Receives CDSCO Approval for Durvalumab in Unresectable Hepatocellular Carcinoma
AstraZeneca Pharma India Ltd. (AZPIL), a global, science-led biopharmaceutical company, has announced that the Central Drugs Standard Control Organisation (CDSCO)…
